Activists hold a demonstration outside of Eli Lilly offices in New York City on September 5, 2019. (Photo: Erik McGregor/LightRocket via Getty Images)
Sep 30, 2020
A coalition of progressive advocacy groups fighting to lower drug prices in the U.S. took President Donald Trump to task Wednesday for falsely claiming during the first 2020 general election debate that his administration made insulin "cheap like water," an assertion belied by the large sums Americans continue to pay for the lifesaving diabetes medicine.
"Calling insulin 'cheap as water' reveals just how out of touch this president is with the millions of Americans who must continue to ration critical medicines every single day."
--Margarida Jorge, Lower Drug Prices Now
"Like just about everything else he has said over the last five years, Donald Trump's claims on lowering drug prices in last night's debate, particularly his outrageous claim about insulin, were nothing but spin and lies," Margarida Jorge, campaign director for Lower Drug Prices Now, said in a statement.
"Calling insulin 'cheap as water' reveals just how out of touch this president is with the millions of Americans who must continue to ration critical medicines every single day because of Trump's failure to follow through on his promises to hold Big Pharma accountable and lower drug prices," Jorge continued. "Drug prices for Americans are the highest in the world, and three and a half years into Trump's presidency--in the middle of a pandemic--the prices have continued to go up faster than any other medical good or service."
During a discussion on healthcare at Tuesday night's presidential debate, Trump touted his administration's supposed success in lowering the costs of insulin and other prescription medicines.
"I'll give you an example: Insulin. it was destroying families, destroying people, the cost. I'm getting it for so cheap it's like water, you want to know the truth. So cheap," Trump said, remarks that were not met with any real-time pushback from Democratic presidential nominee Joe Biden or debate moderator Chris Wallace.
\u201cTrump just claimed that insulin is \u201cas cheap as water\u201d ... I don\u2019t know what kind of water he is referring to. \n\nThis list of insulin prices shows President Trump hasn't done jack about drug prices. He's claiming credit for something he's done nothing about. #insulinlikewater\u201d— Lower Drug Prices Now (@Lower Drug Prices Now) 1601477619
STATreported following the debate that contrary to Trump's claim, "insulin still retails for roughly $300 a vial," and "most patients with diabetes need two to three vials per month, and some can require much more."
Outraged by Trump's comments, several Twitter users posted pictures of receipts for their recent insulin orders:
\u201cSpeaking strictly to the facts, and providing supporting documentation (the receipts for my #insulin) I can confirm it is not currently the same price as water.\u201d— Madison Carter (@Madison Carter) 1601429098
\u201cDonald Trump: "Insulin is so inexpensive it flows like water." \n\nMy Pharmacy:\u201d— Morgan Schechter Shanahan (@Morgan Schechter Shanahan) 1601429230
In late July, Trump signed a series of executive orders that he touted as "historic" initiatives to lower the costs of prescription drugs, including insulin. But critics warned at the time that the orders were largely toothless and would provide little relief to the millions of Americans paying exorbitant costs for drugs that are far cheaper in other wealthy nations.
"While some of these proposals could help a limited number of people access insulin or EpiPens, they are pathetically small compared to the massive executive power Trump could use to make medicine affordable and available for all, if he were willing to stand up to Big Pharma," Peter Maybarduk, director of Public Citizen's Access to Medicines program, told the Los Angeles Times.
As PolitiFactnoted late Tuesday, Trump's insulin executive order "targeted a select group of healthcare providers that represent fewer than 2% of the relevant outlets for insulin. Between 2017 and 2018, insulin prices for seniors rose."
Join Us: News for people demanding a better world
Common Dreams is powered by optimists who believe in the power of informed and engaged citizens to ignite and enact change to make the world a better place. We're hundreds of thousands strong, but every single supporter makes the difference. Your contribution supports this bold media model—free, independent, and dedicated to reporting the facts every day. Stand with us in the fight for economic equality, social justice, human rights, and a more sustainable future. As a people-powered nonprofit news outlet, we cover the issues the corporate media never will. |
Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.
A coalition of progressive advocacy groups fighting to lower drug prices in the U.S. took President Donald Trump to task Wednesday for falsely claiming during the first 2020 general election debate that his administration made insulin "cheap like water," an assertion belied by the large sums Americans continue to pay for the lifesaving diabetes medicine.
"Calling insulin 'cheap as water' reveals just how out of touch this president is with the millions of Americans who must continue to ration critical medicines every single day."
--Margarida Jorge, Lower Drug Prices Now
"Like just about everything else he has said over the last five years, Donald Trump's claims on lowering drug prices in last night's debate, particularly his outrageous claim about insulin, were nothing but spin and lies," Margarida Jorge, campaign director for Lower Drug Prices Now, said in a statement.
"Calling insulin 'cheap as water' reveals just how out of touch this president is with the millions of Americans who must continue to ration critical medicines every single day because of Trump's failure to follow through on his promises to hold Big Pharma accountable and lower drug prices," Jorge continued. "Drug prices for Americans are the highest in the world, and three and a half years into Trump's presidency--in the middle of a pandemic--the prices have continued to go up faster than any other medical good or service."
During a discussion on healthcare at Tuesday night's presidential debate, Trump touted his administration's supposed success in lowering the costs of insulin and other prescription medicines.
"I'll give you an example: Insulin. it was destroying families, destroying people, the cost. I'm getting it for so cheap it's like water, you want to know the truth. So cheap," Trump said, remarks that were not met with any real-time pushback from Democratic presidential nominee Joe Biden or debate moderator Chris Wallace.
\u201cTrump just claimed that insulin is \u201cas cheap as water\u201d ... I don\u2019t know what kind of water he is referring to. \n\nThis list of insulin prices shows President Trump hasn't done jack about drug prices. He's claiming credit for something he's done nothing about. #insulinlikewater\u201d— Lower Drug Prices Now (@Lower Drug Prices Now) 1601477619
STATreported following the debate that contrary to Trump's claim, "insulin still retails for roughly $300 a vial," and "most patients with diabetes need two to three vials per month, and some can require much more."
Outraged by Trump's comments, several Twitter users posted pictures of receipts for their recent insulin orders:
\u201cSpeaking strictly to the facts, and providing supporting documentation (the receipts for my #insulin) I can confirm it is not currently the same price as water.\u201d— Madison Carter (@Madison Carter) 1601429098
\u201cDonald Trump: "Insulin is so inexpensive it flows like water." \n\nMy Pharmacy:\u201d— Morgan Schechter Shanahan (@Morgan Schechter Shanahan) 1601429230
In late July, Trump signed a series of executive orders that he touted as "historic" initiatives to lower the costs of prescription drugs, including insulin. But critics warned at the time that the orders were largely toothless and would provide little relief to the millions of Americans paying exorbitant costs for drugs that are far cheaper in other wealthy nations.
"While some of these proposals could help a limited number of people access insulin or EpiPens, they are pathetically small compared to the massive executive power Trump could use to make medicine affordable and available for all, if he were willing to stand up to Big Pharma," Peter Maybarduk, director of Public Citizen's Access to Medicines program, told the Los Angeles Times.
As PolitiFactnoted late Tuesday, Trump's insulin executive order "targeted a select group of healthcare providers that represent fewer than 2% of the relevant outlets for insulin. Between 2017 and 2018, insulin prices for seniors rose."
A coalition of progressive advocacy groups fighting to lower drug prices in the U.S. took President Donald Trump to task Wednesday for falsely claiming during the first 2020 general election debate that his administration made insulin "cheap like water," an assertion belied by the large sums Americans continue to pay for the lifesaving diabetes medicine.
"Calling insulin 'cheap as water' reveals just how out of touch this president is with the millions of Americans who must continue to ration critical medicines every single day."
--Margarida Jorge, Lower Drug Prices Now
"Like just about everything else he has said over the last five years, Donald Trump's claims on lowering drug prices in last night's debate, particularly his outrageous claim about insulin, were nothing but spin and lies," Margarida Jorge, campaign director for Lower Drug Prices Now, said in a statement.
"Calling insulin 'cheap as water' reveals just how out of touch this president is with the millions of Americans who must continue to ration critical medicines every single day because of Trump's failure to follow through on his promises to hold Big Pharma accountable and lower drug prices," Jorge continued. "Drug prices for Americans are the highest in the world, and three and a half years into Trump's presidency--in the middle of a pandemic--the prices have continued to go up faster than any other medical good or service."
During a discussion on healthcare at Tuesday night's presidential debate, Trump touted his administration's supposed success in lowering the costs of insulin and other prescription medicines.
"I'll give you an example: Insulin. it was destroying families, destroying people, the cost. I'm getting it for so cheap it's like water, you want to know the truth. So cheap," Trump said, remarks that were not met with any real-time pushback from Democratic presidential nominee Joe Biden or debate moderator Chris Wallace.
\u201cTrump just claimed that insulin is \u201cas cheap as water\u201d ... I don\u2019t know what kind of water he is referring to. \n\nThis list of insulin prices shows President Trump hasn't done jack about drug prices. He's claiming credit for something he's done nothing about. #insulinlikewater\u201d— Lower Drug Prices Now (@Lower Drug Prices Now) 1601477619
STATreported following the debate that contrary to Trump's claim, "insulin still retails for roughly $300 a vial," and "most patients with diabetes need two to three vials per month, and some can require much more."
Outraged by Trump's comments, several Twitter users posted pictures of receipts for their recent insulin orders:
\u201cSpeaking strictly to the facts, and providing supporting documentation (the receipts for my #insulin) I can confirm it is not currently the same price as water.\u201d— Madison Carter (@Madison Carter) 1601429098
\u201cDonald Trump: "Insulin is so inexpensive it flows like water." \n\nMy Pharmacy:\u201d— Morgan Schechter Shanahan (@Morgan Schechter Shanahan) 1601429230
In late July, Trump signed a series of executive orders that he touted as "historic" initiatives to lower the costs of prescription drugs, including insulin. But critics warned at the time that the orders were largely toothless and would provide little relief to the millions of Americans paying exorbitant costs for drugs that are far cheaper in other wealthy nations.
"While some of these proposals could help a limited number of people access insulin or EpiPens, they are pathetically small compared to the massive executive power Trump could use to make medicine affordable and available for all, if he were willing to stand up to Big Pharma," Peter Maybarduk, director of Public Citizen's Access to Medicines program, told the Los Angeles Times.
As PolitiFactnoted late Tuesday, Trump's insulin executive order "targeted a select group of healthcare providers that represent fewer than 2% of the relevant outlets for insulin. Between 2017 and 2018, insulin prices for seniors rose."
We've had enough. The 1% own and operate the corporate media. They are doing everything they can to defend the status quo, squash dissent and protect the wealthy and the powerful. The Common Dreams media model is different. We cover the news that matters to the 99%. Our mission? To inform. To inspire. To ignite change for the common good. How? Nonprofit. Independent. Reader-supported. Free to read. Free to republish. Free to share. With no advertising. No paywalls. No selling of your data. Thousands of small donations fund our newsroom and allow us to continue publishing. Can you chip in? We can't do it without you. Thank you.